Category Press Releases

Lotus Neuro Launches to Advance Next-Generation Blood-Brain Barrier Therapies

Lotus Neuro Launches to Advance Focused Ultrasound Drug Delivery for Neurological Diseases Lotus Neuro, a clinical-stage biotechnology company focused on combining focused ultrasound with therapeutic medicines to address focal neurological diseases, has announced its public launch. The company is developing…

Read MoreLotus Neuro Launches to Advance Next-Generation Blood-Brain Barrier Therapies

restor3d Launches MyFit Digital Suite to Expand Personalized Orthopedic Care

restor3d Launches MyFit Digital Suite to Enhance Personalized Orthopedic Patient Experience restor3d, a leader in personalized 3D-printed orthopedic solutions, has announced the launch of MyFit by restor3d Digital Suite, a new patient engagement ecosystem designed to give patients greater visibility…

Read Morerestor3d Launches MyFit Digital Suite to Expand Personalized Orthopedic Care

Agilent Announces Board Chair Retirement and Appoints Glenn Boehnlein to Board of Directors

Agilent Technologies Announces Board Leadership Transition and Appointment of Glenn Boehnlein Agilent Technologies Inc. (NYSE: A) has announced a series of leadership changes to its board of directors, marking an important transition in the company’s governance structure. Koh Boon Hwee,…

Read MoreAgilent Announces Board Chair Retirement and Appoints Glenn Boehnlein to Board of Directors

Aptar and Aceso Therapeutics Collaborate to Advance Inhaled Antisense Therapy for Cystic Fibrosis

Aptar Pharma and Aceso Therapeutics Collaborate to Advance Inhaled ASO Therapy for Cystic Fibrosis Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and development services, has announced a new collaboration with Aceso Therapeutics, a biotechnology company focused…

Read MoreAptar and Aceso Therapeutics Collaborate to Advance Inhaled Antisense Therapy for Cystic Fibrosis

Segal Trials Launches CISCRP’s 8th Annual Medical Heroes Appreci-A-Thon

Segal Trials Employees Join CISCRP Medical Heroes Appreci-A-Thon to Honor Clinical Research Participants and Professionals More than 90 employees from Segal Trials are participating in the 8th Annual Medical Heroes Appreci-A-Thon organized by the Center for Information and Study on…

Read MoreSegal Trials Launches CISCRP’s 8th Annual Medical Heroes Appreci-A-Thon

Biocytogen Signs VHH Antibody Licensing Deal with Qilu Pharmaceutical

Biocytogen and Qilu Pharmaceutical Enter Non-Exclusive Licensing Agreement for Fully Human VHH Antibody in Neuroscience Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SSE: 688796; HKEX: 02315), a biotechnology company focused on the discovery and development of innovative antibody-based therapeutics, has entered into…

Read MoreBiocytogen Signs VHH Antibody Licensing Deal with Qilu Pharmaceutical

Huonslab Secures Patent for Therapeutic Antibody Subcutaneous Injection Formulation Using HyDIFFUZE™ Platform

Huonslab Expands Intellectual Property Portfolio for HyDIFFUZE™ Platform to Advance Subcutaneous Biologic Drug Delivery Huonslab, the research and development subsidiary of Huons Global (KOSDAQ: 084110), has strengthened its position in the rapidly evolving biologics market by securing new intellectual property…

Read MoreHuonslab Secures Patent for Therapeutic Antibody Subcutaneous Injection Formulation Using HyDIFFUZE™ Platform

Logan University Health Centers Partner with Arete Healthcare to Expand Patient Access and Modernize Care

Logan University Health Centers and Arete Healthcare Partner to Expand Patient Access and Modernize Clinical Care Logan University Health Centers has announced a strategic partnership with Arete Healthcare aimed at expanding access to healthcare, improving clinical operations, and creating stronger…

Read MoreLogan University Health Centers Partner with Arete Healthcare to Expand Patient Access and Modernize Care

New Neurology Study Strengthens Evidence for Quantitative MRI Biomarkers in SBMA Muscle Assessment

New Study in Neurology Highlights the Potential of Quantitative MRI Biomarkers for Assessing Muscle Changes in SBMA AMRA Medical has announced the publication of new research in Neurology demonstrating the potential of quantitative whole-body magnetic resonance imaging (MRI) to measure…

Read MoreNew Neurology Study Strengthens Evidence for Quantitative MRI Biomarkers in SBMA Muscle Assessment

Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology

Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology Summit Therapeutics Inc. has announced the publication of primary analysis results from its global Phase III HARMONi clinical trial in The Lancet Oncology, providing peer-reviewed evidence supporting the…

Read MoreIvonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology

Copia Scientific Partners with HSE•AG to Expand Automated Nucleic Acid Quantification in North America

Copia Scientific and HSE•AG Partner to Expand On-Deck Nucleic Acid Quantification for Laboratory Automation Copia Scientific, a provider of laboratory automation, equipment, integration and technical service solutions, has announced a new distribution agreement with HSE•AG, a Switzerland-based developer and manufacturer…

Read MoreCopia Scientific Partners with HSE•AG to Expand Automated Nucleic Acid Quantification in North America